Topic

Xospata (gilteritinib)

A collection of 2 issues

Myths vs. Facts: Getting Xospata (Gilteritinib) Covered by Aetna (CVS Health) in Georgia

Quick Answer: Getting Xospata Coverage in Georgia Fact: Aetna requires prior authorization for Xospata (gilteritinib), but approval is achievable with proper documentation. You need: confirmed FLT3 mutation testing, relapsed/refractory AML diagnosis, hematologist-oncologist prescriber, and documentation of prior therapy failures. If denied, Georgia residents have 180 days for internal appeals

How to Get Xospata (Gilteritinib) Covered by Aetna CVS Health in California: Timeline, Appeals, and Approval Steps

Answer Box: Getting Xospata Covered by Aetna CVS Health in California Xospata (gilteritinib) requires prior authorization from Aetna CVS Health but is covered for relapsed/refractory AML with FLT3 mutations. Most approvals happen within 24 hours of complete submission. Key requirements: confirmed FLT3 mutation test, AML diagnosis, and prior therapy